Is protein restriction recommended as a strategy to reduce the risk of developing hepatic encephalopathy?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

Is protein restriction recommended as a strategy to reduce the risk of developing hepatic encephalopathy?

Explanation:
Protein restriction is not recommended as a strategy to reduce hepatic encephalopathy risk. Maintaining adequate protein intake is important in liver disease because amino acids support overall nutrition and muscle mass, and muscles help detoxify ammonia. Restricting protein can worsen malnutrition and sarcopenia, which can actually impair ammonia handling and worsen outcomes. Instead, manage encephalopathy by lowering gut ammonia production through therapies like lactulose and rifaximin, and address precipitating factors. The emphasis is on adequate protein—often with attention to protein quality (for example, plant-based or branched-chain amino acids when appropriate)—rather than restricting intake, in both cirrhosis and acute episodes.

Protein restriction is not recommended as a strategy to reduce hepatic encephalopathy risk. Maintaining adequate protein intake is important in liver disease because amino acids support overall nutrition and muscle mass, and muscles help detoxify ammonia. Restricting protein can worsen malnutrition and sarcopenia, which can actually impair ammonia handling and worsen outcomes. Instead, manage encephalopathy by lowering gut ammonia production through therapies like lactulose and rifaximin, and address precipitating factors. The emphasis is on adequate protein—often with attention to protein quality (for example, plant-based or branched-chain amino acids when appropriate)—rather than restricting intake, in both cirrhosis and acute episodes.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy